The study demonstrated that breast cancer cells expressing elevated levels of RNF126 exhibited heightened replication stress and increased sensitivity to CHEK1 inhibitors, providing further insights into the intricate associations between CHEK1, RNF126, and breast cancer outcomes. The gene discussed is RNF126; the disease is breast carcinoma.